DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$21
185% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
100% 1-yr DAWN win rate
6 Aug ‘25 2 months ago
Needham
Needham
Ami Fadia
40% 1-yr DAWN win rate
6 Aug ‘25 2 months ago